Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangran Feng

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
International Journal of Biological Macromolecules|February 24, 2020
Interfacing DNA with nanoparticles: Surface science and its applications in biosensingQunye He, Qing Wu, Xiangran Feng, et al.
Cancer Cell International|February 24, 2024
Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalitiesMengchen Lyu, Lifeng Luo, Ling Zhou, et al.
International Immunopharmacology|September 23, 2024
The predict factors and clinical prognosis value of immune-related pneumonia of receiving PD-1 inhibitor in advanced non-small cell lung cancer: A retrospective studyJin Yang, Mengchen Lyu, Xiangran Feng, et al.
Plant Physiology|October 4, 2024
An effector protein of Fusarium graminearum targets chloroplasts and suppresses cyclic photosynthetic electron flowMinxia Jin, Su Hu, Qin Wu, et al.
Frontiers in Oncology|April 17, 2025
Clinical and molecular characteristics, therapeutic strategies, and prognosis of non-small cell lung cancer patients harboring primary and acquired BRAF mutationsXiangran Feng, Ran Zeng, Mengchen Lyu, et al.
Translational Lung Cancer Research|January 20, 2025
EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAF<sup>V600E</sup> mutation: a multi-center real-world experience in ChinaWenyue Yang, Xiangran Feng, Jian Ni, et al.
Discover Oncology|June 5, 2023
SDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patientsRan Zeng, Xiaoyun Fan, Jin Yang, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
International Journal of Biological Macromolecules|February 24, 2020
Interfacing DNA with nanoparticles: Surface science and its applications in biosensingQunye He, Qing Wu, Xiangran Feng, et al.
Cancer Cell International|February 24, 2024
Emerging trends in the coexistence of primary lung Cancer and hematologic malignancy: a comprehensive analysis of clinicopathological features and genetic abnormalitiesMengchen Lyu, Lifeng Luo, Ling Zhou, et al.
International Immunopharmacology|September 23, 2024
The predict factors and clinical prognosis value of immune-related pneumonia of receiving PD-1 inhibitor in advanced non-small cell lung cancer: A retrospective studyJin Yang, Mengchen Lyu, Xiangran Feng, et al.
Plant Physiology|October 4, 2024
An effector protein of Fusarium graminearum targets chloroplasts and suppresses cyclic photosynthetic electron flowMinxia Jin, Su Hu, Qin Wu, et al.
Frontiers in Oncology|April 17, 2025
Clinical and molecular characteristics, therapeutic strategies, and prognosis of non-small cell lung cancer patients harboring primary and acquired BRAF mutationsXiangran Feng, Ran Zeng, Mengchen Lyu, et al.
Translational Lung Cancer Research|January 20, 2025
EGFR inhibitors plus dabrafenib and trametinib in patients with EGFR-mutant lung cancer and resistance mediated by BRAF<sup>V600E</sup> mutation: a multi-center real-world experience in ChinaWenyue Yang, Xiangran Feng, Jian Ni, et al.
Discover Oncology|June 5, 2023
SDH mutations, as potential predictor of chemotherapy prognosis in small cell lung cancer patientsRan Zeng, Xiaoyun Fan, Jin Yang, et al.
Pageof 1